Writing in the New England Journal of Medicine, the Jupiter group described a study of statin drugs in people with high
C-reactive
protein and low cholesterol. (1) High
C-reactive
protein levels are associated with inflammation and heart disease/stroke. The authors concluded that, in apparently healthy persons with elevated C-reactive protein levels, rosuvastatin (Crestor) significantly reduced the incidence of major cardiovascular events.